The act commonly associated with labeling oversight of drugs and cosmetics is which?

Study for the FIPA 2 Exam 3. Hone your skills with flashcards and multiple choice questions, each question with hints and explanations. Prepare for your exam confidently!

Multiple Choice

The act commonly associated with labeling oversight of drugs and cosmetics is which?

Explanation:
Labeling oversight for drugs and cosmetics is anchored in the Federal Food, Drug, and Cosmetic Act. This law gave the FDA authority to regulate how these products are labeled, requiring labels to be truthful and not misleading and to include essential information such as active ingredients, strength, directions for use, and safety warnings. It established the framework that ensures products on the market carry accurate labeling and that any claims are properly supported. The other acts address different aspects: the Harris-Kefauver Amendments focus on proving drug safety and effectiveness before approval; the Orphan Drug Act provides incentives for developing treatments for rare diseases; the Shirley Amendments were an earlier attempt to curb false labeling but did not establish the broad, ongoing labeling oversight that the Federal Food, Drug, and Cosmetic Act provides.

Labeling oversight for drugs and cosmetics is anchored in the Federal Food, Drug, and Cosmetic Act. This law gave the FDA authority to regulate how these products are labeled, requiring labels to be truthful and not misleading and to include essential information such as active ingredients, strength, directions for use, and safety warnings. It established the framework that ensures products on the market carry accurate labeling and that any claims are properly supported.

The other acts address different aspects: the Harris-Kefauver Amendments focus on proving drug safety and effectiveness before approval; the Orphan Drug Act provides incentives for developing treatments for rare diseases; the Shirley Amendments were an earlier attempt to curb false labeling but did not establish the broad, ongoing labeling oversight that the Federal Food, Drug, and Cosmetic Act provides.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy